Macleods Pharma USA, Inc. is recalling 3,672 bottles of Amlodipine and Olmesartan Medoxomil Tablets (10 mg / 20 mg) because of manufacturing deviations that do not meet quality standards. These prescription tablets are used to treat high blood pressure and were distributed nationwide in 30-count bottles. No injuries or health incidents have been reported in connection with this recall.
The manufacturing issues, known as cGMP deviations, mean the medication may not meet the required safety and quality standards set by the FDA. This could potentially affect the strength or purity of the medication, which may impact how well it controls blood pressure.
You have 2 options:
Recall #: D-0632-2022. Total quantity: 3,672 bottles.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.